26-05-2025
Tony's Takeaway: Tryptamine Therapeutics and the psychedelic sector
Tony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998. He's focused on the small cap and emerging companies with a strong interest in identifying those in the mining, biotech and industrial sectors that offer growth potential.
He also delves into the psychology of speculation and provides regular insights on a number of social media and finance related outlets.
This week, Tony checks out an emerging psychedelic healthcare sector with some big developments and an Australian company in Tryptamine Therapeutics (ASX:TYP) who has recently made an eye-opening appointment of a global pharmaceuticals leader.
The views, information, or opinions expressed in this video are solely those of the author and do not represent the views of Stockhead.
Stockhead has not provided, endorsed or otherwise assumed responsibility for any financial product advice contained in this video. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
